Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
US6054567A · kind A · utility
6Cited by
3References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 11, 1997 |
| Grant date | Apr 25, 2000 |
| Priority date | — |
| Expiry date | Apr 11, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the expression of open reading frame 2 (ORF-2) proteins of a strain of hepatitis E virus from Pakistan (SAR-55) in a eukaryotic expression system. The expressed proteins can serve as an antigen in diagnostic immunoassays and/or as an immunogen or vaccine to protect against infection by hepatitis E.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.